Revotek Co., Ltd.
Revotek is a vertically integrated 3D bio-printing company currently specializing in vascular structures for research and clinical applications. In December 2016, Revotek became the first company in the world to successfully print and implant 3D bio-printed blood vessels that were fully accepted within living hosts using bio-ink derived from each recipient`s own fat tissue. 3D Bioprinting 3D Bio-printing 3D Bio-printer 3D Bioprinter organ fabrication artificial organ artificial blood vessel. He unveiled techniques that would improve the quality of life for 2 billion people worldwide.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Revotek initiated a unique 3D Bioprinting system which takes “Biosynsphere” as core technology, utilizes RevoCloud Mega Data computing platform as a “mapping” tool, and takes Revotek 3D Bioprinters as the fabricating tool. This system makes fabrication of personalized functional human organs possible.
Our unique suite of technologies includes:
- Biosynsphere™: Specialized bio-ink preparations that enable scaffold free bio-printing
- Bioprinters: T and B series printers with specialized nozzles and platforms to print synthetic and bio-materials
- RevoCloud™: 2D to 3D image conversion technology
In December 2016, we became the first known company to successfully implant a 3D printed organ into living hosts during a series of animal trials using our proprietary and patented technologies. Every one of our test subjects survived and fully accepted the bio-grafts.
Revotek has been granted 14 patents to date with an additional 56 under review with new submissions added regularly as we continue developing our technology and methods.
We are currently in discussions with the US FDA seeking approval to begin clinical trials for our 3D bio-grafts.